Search
for
Sort by
Research 421–450 of 1000+
- Ottawa, Ontario, Canada, February 13–16, 2013
- COVID-19 Can Exacerbate Pattern Hair Loss and Trigger Telogen Effluvium - The Role of Proteoglycan Replacement Therapy with Nourkrin® in Clinical Treatment of COVID-19 Associated Hair Loss
- Coffea arabica: An Emerging Active Ingredient in Dermato-Cosmetic Applications
- Emerging Therapies for Acne Vulgaris
- COVID-19 and Sex Differences
- Skin, a mirror reflecting diabetes mellitus: A longitudinal study in a tertiary care hospital in Gujarat
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- Biomedical Applications of Bee Venom: A Natural Approach to Cancer, Infections, and Inflammatory Diseases
- Cosmetic Applications of Bee Venom
- Insulin-like growth factor 1 and hair growth
- The gut‐microbiota‐brain axis: Focus on gut steroids
- COVID-19 and androgenic status: testosterone or dihydrotestosterone have a pivotal role?
- Hormonal interventions in skin wounds – a mini review
- Inhibition of 17α-hydroxylase/C17,20 lyase reduces gating deficits consequent to dopaminergic activation
- Topical L‐thyroxine: The Cinderella among hormones waiting to dance on the floor of dermatological therapy?
- Epitestosterone
- The Evolution of Emerging Nanovesicle Technologies for Enhanced Delivery of Molecules into and across the Skin
- BH03: Systemic sclerosis and frontal fibrosing alopecia: a novel combination of scarring alopecia
- Androgens in SARS-CoV-2 Coronavirus Infections
- Systemic causes of hair loss
- Topical use of systemic drugs in dermatology: A comprehensive review
- Hepatoprotective and anti-hyperplastic effects of silver nanoparticles biosynthesised using aqueous extracts of <i>M. scaber</i> : Insights from acetaminophen and testosterone experimental models
- 708 SIG-1451: A topical anti-inflammatory new chemical entity for atopic dermatitis (AD)
- Characterizing hair loss in female patients with systemic lupus erythematosus (SLE)
- An atypical clinical presentation of alopecia in 2 patients with systemic lupus erythematosus
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- Topical latanoprost acid for female androgenetic alopecia: a pilot proof-of-concept trial with mechanistic evidence of prostaglandin F2α receptor activation
- Analysis of androgen receptor expression and activity in the mouse brain
- Regulatory roles of androgens in cutaneous wound healing
- Alterations in androgen conjugate levels in women and men with alopecia